可溶性CCR2-表达的介酶干细胞抑制了骨关节炎的发展和进展
Hyun Sik Na1, Seon-Young Lee1, Dong Hwan Lee2
1Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Immune network
|July 7, 2025
概括
可溶性C-C化基因受体2型 (sCCR2) 表达干细胞 (sCEMs) 通过抑制MCP-1,减少疼痛和保护软骨,提供优越的关节炎治疗. 这种基因疗法对OA具有显著的治疗潜力.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
背景情况:
- 骨关节炎 (OA) 是一种退行性关节疾病,通常用止痛药或干细胞治疗.
- 之前的研究表明,可溶性C-C化学因子受体2型 (sCCR2) 基因治疗对OA的治疗效果.
- 介质细胞干细胞 (MSCs) 正在探索软骨修复,但它们的疗效可以提高.
研究的目的:
- 评估sCCR2-表达的MSCs (sCEMs) 在OA模型中是否表现出优于单独的MSCs的疗效.
- 研究sCEMs在抑制OA进展中的治疗机制.
- 评估sCEMs作为有效的OA治疗的潜力.
主要方法:
- 一种骨关节炎 (OA) 鼠标模型是使用单酸诱导建立的.
- 可溶性C-C基因受体2型 (sCCR2) 被转移到红细胞和MSC中,以创建sCEM.
- 进行了体外和体内实验,包括对MCP-1条件淘汰赛小鼠的分析.
主要成果:
- 发现MCP-1可以抑制体生成,而sCEM则证明了体生成的改善.
- 在大鼠模型中,sCEM治疗显著抑制了OA疾病的发展.
- 与MOCK-MSCs相比,sCEM注射减少了OA老鼠的疼痛,炎症和软骨损伤.
结论:
- sCEMs有效抑制MCP-1,导致OA的疼痛和软骨损伤减少.
- 这些发现表明sCEMs具有冠状体保护性质.
- 抑制MCP-1/CCR2信号传递是一种有前途的骨关节炎治疗策略.
更多相关视频
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
4.6K
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
20.0K
相关概念视频
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
